Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PepGen Inc. - Common Stock (NQ: PEPG )

2.430 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 567,704
Open 2.430
Bid (Size) 2.310 (7)
Ask (Size) 2.330 (4)
Prev. Close 2.430
Today's Range 2.430 - 2.430
52wk Range 1.160 - 19.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?
The rally follows PepGen's release of early clinical data from its Phase 1 trial evaluating its therapy to treat a rare genetic disorder. 
Via Stocktwits
These stocks are moving in today's after hours session
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill

Performance

YTD
-35.54%
-35.54%
1 Month
+23.35%
+23.35%
3 Month
-51.88%
-51.88%
6 Month
-73.73%
-73.73%
1 Year
-83.56%
-83.56%

More News

Read More
Which stocks are experiencing notable movement on Thursday?
Via Chartmill
Which stocks are moving on Thursday?
Via Chartmill
What's Driving the Market Sentiment Around PepGen?
Via Benzinga
Why PepGen (PEPG) Stock Is Skyrocketing Today
Via Benzinga
Top movers in Monday's session
Via Chartmill
These stocks are making the most noise in today's session.
Via Chartmill
These stocks are moving in today's session
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
From PepGen Inc.
Via Business Wire
PepGen Announces CONNECT Program Updates
From PepGen Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy
From PepGen Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
From PepGen Inc.
Via Business Wire
Roku To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
PepGen to Participate in Upcoming Investor Conferences
From PepGen Inc.
Via Business Wire
PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society
From PepGen Inc.
Via Business Wire
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Via MarketBeat
Exposures Product Safety
PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors
From PepGen Inc.
Via Business Wire
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development
From PepGen Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.